Targeting DNA repair as a promising approach in cancer therapy

Giovanna Damia, Maurizio D'Incalci

Research output: Contribution to journalArticlepeer-review


An increased DNA-repair activity in tumour cells has been associated with resistance to treatment to DNA-directed drugs, while defects in DNA repair pathways result in hypersensitivity to these agents. In the past years the unravelling of the molecular basis of these DNA pathways, with a better understanding of the DNA damage caused by different anticancer agents, has provided the rationale for the use of some DNA repair inhibitors to optimise the therapeutic use of DNA-damaging agents currently used in the treatment of tumours. In addition, the possibility to specifically target the differences in DNA repair capacity between normal and tumour cells has recently emerged as an exciting possibility. The present review will mainly cover those approaches that are currently under clinical investigation.

Original languageEnglish
Pages (from-to)1791-1801
Number of pages11
JournalEuropean Journal of Cancer
Issue number12
Publication statusPublished - Aug 2007


  • Anticancer drugs
  • DNA repair

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Targeting DNA repair as a promising approach in cancer therapy'. Together they form a unique fingerprint.

Cite this